NCT01124851View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ABT-652 in Subjects With Excessive Daytime Sleepiness

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Sleep Disorder
Interventions
DRUG

ABT-652

See arm description for details

DRUG

Placebo

See arm description for details

Trial Locations (5)

10019

Site Reference ID/Investigator# 40402, New York

27710

Site Reference ID/Investigator# 38122, Durham

85006

Site Reference ID/Investigator# 43241, Phoenix

91206

Site Reference ID/Investigator# 38092, Glendale

92103

Site Reference ID/Investigator# 43264, San Diego

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY